NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Assets | ₹433 Cr | ₹356 Cr | ₹287 Cr | ₹277 Cr | ₹207 Cr |
What is the latest Total Assets ratio of NGL FINECHEM ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹433 Cr |
| Mar2024 | ₹356 Cr |
| Mar2023 | ₹287 Cr |
| Mar2022 | ₹277 Cr |
| Mar2021 | ₹207 Cr |
How is Total Assets of NGL FINECHEM Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹433 Cr | 21.90 | |
| Mar2024 | ₹356 Cr | 23.85 | |
| Mar2023 | ₹287 Cr | 3.67 | |
| Mar2022 | ₹277 Cr | 33.53 | |
| Mar2021 | ₹207 Cr | - | |
Compare Total Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,398.1 Cr | -4.9% | -3.6% | 113.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -4.9% |
-3.6% |
113.8% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses